Objective: Frasier syndrome is a rare genetic nephropathy characterized by the presence of progressive glomerulopathy with proteinuria associated with male pseudo hermaphroditism. This case study described a picture of a young boy where the clinical suspicion context reminded the Frasier syndrome. To our knowledge, this case is the first described in Haiti. Case Study: This is a 19-year-old young phenotypically male, born with a genital anomaly, was seen on referral at the nephrology/dialysis unit of the internal medicine department of the State University Hospital of Haiti for evaluation and follow-up. Insidious progression of symptoms had occurred over 3 years. Over three months of outpatient follow-up, he had four sets of renal labs drawn, and all showed impaired renal function. At the ultrasound, a bilateral cryptorchidism is described in the inguinal, and presence of functional ovaries with follicles of variable size scattered in the parenchyma. So, in the light of these anamnestic, clinical and paraclinical findings, we concluded to the diagnosis of end-stage renal failure by progressive glomerulopathy in a context of Frasier’s syndrome. Conclusion: With any clinical picture consisting of genital anomalies at birth, renal symptomatology during childhood and the diagnosis of renal failure during adolescence, rare genetic nephropathies, such as Frasier syndrome must be considered.
Abdominal gunshot trauma is the third leading cause of death and is responsible for more than 90% of deaths among people ages 15 to 24 years old. It can cause multi-system organ damage, shock, and infection. We present a case of a through-and-through abdominal bullet wound where laparotomy exploration has found nothing as damage inside the abdomen.
INTRODUCTION: Breast cancer (BC) is the most prominent cancer in females and is cited as a leading cause of cancer-related mortality in women worldwide. We aimed to determine factors influencing adherence to surgery and chemotherapy in women with BC in Mbingo Baptist Hospital (MBH). METHODS: we conducted a cross-sectional study in the MBH-Cameroon. Purposeful sampling was used to select participants for investigation. A structured questionnaire was applied to 82 women on chemotherapy in the oncology unit. Socio-demographic, clinical, and therapeutic data were collected from participants. The Morisky Medication Scale (MMS) was used to assess the patient´s motivation and knowledge while the Adherence Starts with Knowledge (ASK12) questionnaire was used to measure the patient´s barriers to treatment. SPSS was used for data analysis. RESULTS: the mean age was 46.37 (SD 11 years). Most participants (67.1%) were in the group of (25-50 years). The majority (75.6%) of respondents attended at least primary school. The results showed that adherence to surgery and chemotherapy is low 44% and 56.1% respectively, and this was greatly influenced by treatment delay (P = 0.034), missed chemotherapy dose without medical indication (P=0.029), patient´s motivation, and knowledge towards their disease and treatment (P=0.0001 and P=0.0001), respectively. CONCLUSION: our results revealed that adherence to surgery and chemotherapy among women with BC in MBH is low and is driven by the patient's motivation, knowledge about the disease, and treatment.
10 October 2025 in JSES Reviews, Reports, and Techniques
Total elbow arthroplasty (TEA) is a surgical procedure used in the management of arthritis and fractures. Outpatient total elbow arthroplasty (OTEA) could be a valid option to reduce workforce burden and cost, provided it can be proven to be equally safe and effective as inpatient TEA. This meta-analysis was conducted to evaluate the efficacy and safety of OTEA. A literature search was performed in PubMed, Embase, Scopus, and Google Scholar using DistillerSR, with predetermined keywords based on the Patient/Problem, Intervention, Control, and Outcome criteria. Studies characterizing OTEA and/or inpatient TEA were included. Total readmissions, revision rates, cost difference, and functional outcome scores were assessed for outpatient vs. inpatient TEA. Risk of bias assessment was performed using the Risk of Bias in Nonrandomized Studies of Interventions tool. Five studies fulfilled the inclusion criteria. Seven hundred twenty-five patients in the outpatient group and 1,461 patients in the inpatient group (control). Incidence of complications was significantly higher in the inpatient cohort compared to the outpatient TEAs (inpatient n = 121 (%) vs. outpatient n = 51 (%), P = .037) Readmissions occurred in 84/1,166 cases (7%). There was no significant difference in the readmission rate between the inpatient (57/745, 7%) and the outpatient (27/421, 6%). The cost of OTEA was lower than inpatient TEA, with a mean of 26, 817 USD in the inpatient group when compared to 18,412 USD for OTEA. Clinical results of outpatient vs. inpatient TEA were similar with respect to overall complications, readmissions, and functional scores, and outpatient TEA was more cost effective. Our review indicates that outpatient TEA can be considered by individual care providers after development of appropriate local pathways. This review highlights the need for further high-quality studies in this niche but clinically important field.